| Gene | Disease | Score gda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
0.550 | GenomicAlterations | CGI | |||||||||||
|
|
0.410 | Biomarker | CTD_human | |||||||||||
|
|
0.410 | CausalMutation | CLINVAR | |||||||||||
|
|
0.410 | Biomarker | HPO | |||||||||||
|
|
0.400 | GenomicAlterations | CGI | |||||||||||
|
|
0.340 | CausalMutation | CGI | |||||||||||
|
|
0.330 | GenomicAlterations | CGI | |||||||||||
|
|
0.330 | GenomicAlterations | CGI | |||||||||||
|
|
0.330 | CausalMutation | CGI | |||||||||||
|
|
0.300 | Biomarker | GENOMICS_ENGLAND | |||||||||||
|
|
0.180 | Biomarker | HPO | |||||||||||
|
|
0.180 | Biomarker | HPO | |||||||||||
|
|
0.110 | Biomarker | HPO | |||||||||||
|
|
0.110 | Biomarker | HPO | |||||||||||
|
|
0.110 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.010 | Biomarker | BEFREE | In the next generation, one member died of Hodgkin's disease; four of nine healthy persons had impaired lymphocyte transformation in vitro in response to phytohemagglutinin-P (PHA-P), and three of these had polyclonal elevations in IgM levels. | 806230 | 1975 |
||||||||
|
|
0.090 | Biomarker | BEFREE | Over 200 cases of non-Hodgkin's lymphoma were typed for HLA-A, B, C and DR antigens, and typing was correlated with the morphologic diagnosis according to the Lukes-Collins classification system of non-Hodgkin's lymphomas. | 6760459 | 1982 |
||||||||
|
|
0.090 | Biomarker | BEFREE | HLA-A, -B, -C, and -DR antigens were determined in order to study the association of HLA in Japanese patients with several autoimmune diseases, hypertrophic cardiomyopathy, and Hodgkin's disease. | 6954729 | 1982 |
||||||||
|
|
0.020 | Biomarker | BEFREE | Serum alpha-1-acid-glycoprotein, haptoglobin and C3 in Hodgkin's disease. A comparison with other acute-phase indicators. | 6180585 | 1982 |